UNASSIGNED: To describe sociodemographic and clinical characteristics of the InDePendent study population with particular reference to determinants of unmet needs.
UNASSIGNED: We analyzed baseline data of the multi-centre cluster-randomized controlled trial (InDePendent) using descriptive statistics to describe patients\' sociodemographic and clinical characteristics and Poisson regression models to predict unmet needs, separated by sex. Data were collected personally via face-to-face interviews.
UNASSIGNED: Most of the n = 417 participating PlwD were mild to moderately cognitively impaired, were not depressed, had an average of 10.8 diagnoses, took 6.7 medications, and had, on average, 2.4 unmet needs (62% of PlwD had at least one unmet need) measured by the Camberwell Assessment of Need for the Elderly (CANE). Low social support, a high body-mass-index, a lower education, functional impairment, and worse health status were associated with more unmet needs, regardless of sex. In women, higher unmet needs were associated with more depressive symptoms, a poor financial situation, living alone and not being recently treated by a general practitioner. In males, unmet needs increased with the number of medications taken.
UNASSIGNED: PlwD had a broad array of unmet healthcare needs, indicating primary healthcare provision improvement potentials. The results underscore the significance of early assessment of patient\'s clinical characteristics and unmet needs as a basis for individualized gender-sensible intervention strategies.∥ClinicalTrials.gov Identifier: NCT04741932, Registered on February 5, 2021.
■描述InDePendent研究人群的社会人口统计学和临床特征,特别是未满足需求的决定因素。
我们分析了多中心集群随机对照试验(InDependent)的基线数据,使用描述性统计来描述患者的社会人口统计学和临床特征,并使用泊松回归模型来预测未满足的需求,被性别分开。数据是通过面对面采访亲自收集的。
■大多数参与PlwD的n=417人轻度至中度认知受损,并不沮丧,平均有10.8次诊断,服用了6.7种药物,并且有,平均而言,2.4未满足的需求(62%的PlwD至少有一个未满足的需求)通过坎伯韦尔老年人需求评估(CANE)测量。社会支持低,高体重指数,较低的教育,功能损害,健康状况恶化与更多未满足的需求有关,不管性别。在女性中,更高的未满足需求与更多的抑郁症状有关,糟糕的财务状况,独自生活,最近没有接受全科医生的治疗。在男性中,未满足的需求随着服用药物的数量而增加。
■PlwD有广泛的未满足的医疗保健需求,表明初级医疗保健提供改善的潜力。结果强调了早期评估患者的临床特征和未满足的需求作为个性化性别明智干预策略的基础的重要性。C.2ClinicalTrials.gov标识符:NCT04741932,于2021年2月5日注册。